ClinicalTrials.govpublic full text
Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma
renal cell carcinoma, kidney cancer, durvalumab, tremelimumab, phase ib, locally advanced, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 980430
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.